Saudi university begins clinical trials to produce first coronavirus vaccine

Saudi university begins clinical trials to produce first coronavirus vaccine

RIYADH — The Dammam-based Imam Abdul Rahman Bin Faisal University has started the first phase of clinical trials to produce the coronavirus vaccine, and this is with the support of the Ministry of Education.The university has completed the laboratory tests that have proven effective. This step reflects the contribution of Saudi universities and their integration with the national efforts aimed at reaching the first Saudi anti-coronavirus vaccine.The university has signed a contract with one of the largest specialized companies in the United Kingdom and Sweden, which is distinguished by the production of vaccines in large quantities in the world. It had previously worked with leading companies in the production of vaccines and medicines such as AstraZeneca, with the aim of preparing appropriate quantities for use in the first phase of clinical trials.The contract includes the fermentation phase, risk assessment, safety and quality of the plasmid material, as well as the production of the first batch of the vaccine in accordance with international standards and practices for production, and the requirements